Literature DB >> 10617933

Epidemiology and immunopathology of bancroftian filariasis.

A B de Almeida1, D O Freedman.   

Abstract

Human lymphatic filariasis affects 120 million people worldwide. Although the disease is considered to be potentially erradicable by the World Health Organization, comprehensive studies on epidemiological aspects as well as mechanisms of pathology development are still premature. The following review summarizes currently available data on these topics and ends by discussing the latest control strategies.

Entities:  

Mesh：

Year:  1999        PMID： 10617933     DOI： 10.1016/s1286-4579(99)80519-x

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  11 in total

Review 1.  Immunology of parasitic helminth infections.

Authors:  Andrew S MacDonald; Maria Ilma Araujo; Edward J Pearce
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Heightened measures of immune complex and complement function and immune complex-mediated granulocyte activation in human lymphatic filariasis.

Authors:  Prakash Senbagavalli; Rajamanickam Anuradha; Vadakkuppattu D Ramanathan; Vasanthapuram Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

3.  Chyluria and chylothorax after posterior selective fusion for adolescent idiopathic scoliosis.

Authors:  Alexander A Weening; Bernadette Schurink; Jelle P Ruurda; Richard van Hillegersberg; Ronald L A W Bleys; Moyo C Kruyt
Journal:  Eur Spine J       Date:  2017-05-05       Impact factor: 3.134

4.  Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.

Authors:  Jinlong Li; Yan Chen; Li Zhang; Lianping Xing; Hao Xu; Yongjun Wang; Qi Shi; Qianqian Liang
Journal:  J Ethnopharmacol       Date:  2016-08-21       Impact factor: 4.360

5.  Cytochemical characterization of the third-stage larva of Wuchereria bancrofti (Nematoda: Filarioidea).

Authors:  L F Silva; L C Alves; S S Santos; M G S Cavalcanti; C A Peixoto
Journal:  Parasitol Res       Date:  2006-02-01       Impact factor: 2.289

6.  VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Authors:  Young-Sup Yoon; Toshinori Murayama; Edwin Gravereaux; Tengiz Tkebuchava; Marcy Silver; Cynthia Curry; Andrea Wecker; Rudolf Kirchmair; Chun Song Hu; Marianne Kearney; Alan Ashare; David G Jackson; Hajime Kubo; Jeffrey M Isner; Douglas W Losordo
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  Filarial parasites develop faster and reproduce earlier in response to host immune effectors that determine filarial life expectancy.

Authors:  Simon A Babayan; Andrew F Read; Rachel A Lawrence; Odile Bain; Judith E Allen
Journal:  PLoS Biol       Date:  2010-10-19       Impact factor: 8.029

8.  Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis.

Authors:  Suba Nookala; Sundaram Srinivasan; Perumal Kaliraj; Rangarajan Badri Narayanan; Thomas B Nutman
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease.

Authors:  R Anuradha; P Jovvian George; N Pavan Kumar; Michael P Fay; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

Review 10.  Lymphedema and therapeutic lymphangiogenesis.

Authors:  Yukihiro Saito; Hironori Nakagami; Yasufumi Kaneda; Ryuichi Morishita
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.